DC Investment Partners

Verana Networks develops an innovative 5G Radio Access Network solution for service providers that have licensed millimeter wave (mmWave) spectrum. The company focuses on enabling 5G in mmWave spectrum because that is where the largest amount of new spectrum is. For 5G to succeed, it must deliver a 10X-50X increase in speed and capacity. Blazing fast speed and an increase in capacity enable new applications, these new applications create incremental revenue, and incremental revenue is essential to support the business case for 5G.

Kandou Bus SA is a company that specializes in designing high-speed, energy-efficient chip-to-chip links and associated technologies. Founded in 2011 and based in Lausanne, Switzerland, Kandou has developed a unique approach to serial link design that enhances data transfer speeds while minimizing power consumption. Their technology is utilized across various electronic devices, including DRAM, graphics cards, server backplanes, mobile devices, and game consoles, effectively increasing data throughput and extending battery life. Additionally, Kandou's solutions address the growing demand for bandwidth in applications such as routers and FPGAs, where they improve performance while reducing pin counts and overall energy usage. The company operates with a team of skilled scientists and engineers across Switzerland, the UK, and the US, focusing on advancing the capabilities of serial links to support innovative electronic designs.

Werewolf Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative cancer immunotherapies. Founded in 2017, the company is advancing a pipeline of therapeutic candidates designed to stimulate the immune system specifically within the tumor microenvironment. Utilizing its proprietary PREDATOR platform, Werewolf Therapeutics engineers conditionally activated molecules known as INDUKINE, which remain inactive in peripheral tissues but activate selectively in the presence of tumors. This targeted approach aims to enhance both adaptive and innate immune responses, addressing limitations associated with traditional proinflammatory therapies. Through its research and development efforts, Werewolf Therapeutics is committed to transforming cancer treatment.

Verana Networks develops an innovative 5G Radio Access Network solution for service providers that have licensed millimeter wave (mmWave) spectrum. The company focuses on enabling 5G in mmWave spectrum because that is where the largest amount of new spectrum is. For 5G to succeed, it must deliver a 10X-50X increase in speed and capacity. Blazing fast speed and an increase in capacity enable new applications, these new applications create incremental revenue, and incremental revenue is essential to support the business case for 5G.